These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31474819)

  • 1. Brain Structural Correlates of Odor Identification in Mild Cognitive Impairment and Alzheimer's Disease Revealed by Magnetic Resonance Imaging and a Chinese Olfactory Identification Test.
    Wu X; Geng Z; Zhou S; Bai T; Wei L; Ji GJ; Zhu W; Yu Y; Tian Y; Wang K
    Front Neurosci; 2019; 13():842. PubMed ID: 31474819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease.
    Mi Y; Ma X; Du S; Du C; Li X; Tan H; Zhang J; Zhang Q; Shi W; Zhang G; Tian Y
    Front Aging Neurosci; 2023; 15():1068708. PubMed ID: 36861124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment.
    Kamath V; Senjem ML; Spychalla AJ; Chen H; Palta P; Mosley TH; Windham BG; Griswold M; Knopman DS; Gottesman RF; Jack CR; Sharrett AR; Schneider ALC
    J Alzheimers Dis; 2022; 89(1):233-245. PubMed ID: 35871337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Functional Abnormalities of Olfactory-Related Regions in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen B; Wang Q; Zhong X; Mai N; Zhang M; Zhou H; Haehner A; Chen X; Wu Z; Auber LA; Rao D; Liu W; Zheng J; Lin L; Li N; Chen S; Chen B; Hummel T; Ning Y
    Int J Neuropsychopharmacol; 2022 May; 25(5):361-374. PubMed ID: 34893841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease.
    Kjelvik G; Saltvedt I; White LR; Stenumgård P; Sletvold O; Engedal K; Skåtun K; Lyngvær AK; Steffenach HA; Håberg AK
    BMC Neurol; 2014 Aug; 14():168. PubMed ID: 25154749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smaller grey matter volume in the central olfactory system in mild cognitive impairment.
    Jobin B; Boller B; Frasnelli J;
    Exp Gerontol; 2023 Nov; 183():112325. PubMed ID: 37952649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between regional brain volume and olfactory function in very mild amnestic patients.
    Kashibayashi T; Takahashi R; Fujita J; Kamimura N; Okutani F; Kazui H
    J Neurol Sci; 2020 Apr; 411():116686. PubMed ID: 31972350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cerebral blood flow and olfactory function in mild cognitive impairment and Alzheimer's disease.
    Kashibayashi T; Takahashi R; Fujita J; Fujito R; Kamimura N; Okutani F; Kazui H
    Int J Geriatr Psychiatry; 2021 Jul; 36(7):1103-1109. PubMed ID: 33751658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
    Park SJ; Lee JE; Lee KS; Kim JS
    Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of olfactory dysfunction in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
    Bouhaben J; Delgado-Lima AH; Delgado-Losada ML
    Arch Gerontol Geriatr; 2024 Aug; 123():105425. PubMed ID: 38615524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Smell Identification Deficit with Alzheimer's Disease Assessment Scale-Cognitive Subscale, Japanese Version Scores and Brain Atrophy in Patients with Dementia.
    Yoshii F; Onaka H; Kohara S; Ryo M; Takahashi W
    Eur Neurol; 2019; 81(3-4):145-151. PubMed ID: 31242486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
    Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verification of the association between cognitive decline and olfactory dysfunction using a DEmentia screening kit in subjects with Alzheimer's dementia, mild cognitive impairment, and normal cognitive function (DESK study): A multicenter, open-label, interventional study.
    Fukumoto T; Ezaki T; Urakami K
    eNeurologicalSci; 2022 Dec; 29():100439. PubMed ID: 36531966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study.
    Vasavada MM; Martinez B; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
    J Alzheimers Dis; 2017; 59(1):359-368. PubMed ID: 28671131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Human Brain Representation of Odor Identification in Amnestic Mild Cognitive Impairment and Alzheimer's Dementia of Mild Degree.
    Kjelvik G; Evensmoen HR; Hummel T; Engedal K; Selbæk G; Saltvedt I; Håberg AK
    Front Neurol; 2020; 11():607566. PubMed ID: 33519686
    [No Abstract]   [Full Text] [Related]  

  • 17. The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.
    Li L; Ji B; Zhao T; Cui X; Chen J; Wang Z
    PLoS One; 2022; 17(7):e0269787. PubMed ID: 35857782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review on Alzheimer's disease classification from normal controls and mild cognitive impairment using structural MR images.
    Garg N; Choudhry MS; Bodade RM
    J Neurosci Methods; 2023 Jan; 384():109745. PubMed ID: 36395961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of odor identification testing in screening for early-stage Alzheimer's disease.
    Audronyte E; Pakulaite-Kazliene G; Sutnikiene V; Kaubrys G
    Sci Rep; 2023 Apr; 13(1):6075. PubMed ID: 37055436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Structural Changes of Frontal Subregions and Their Correlations with Cognitive Impairment in Patients with Alzheimer's Disease.
    Shi C; Deng H; Deng X; Rao D; Yue W
    J Integr Neurosci; 2023 Jul; 22(4):99. PubMed ID: 37519164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.